New Assay Uses Substance P and Bradykinin as Reporters for Blood Protease Activity

Protocols for using substance P and bradykinin as neuropeptide reporter substrates to measure serum protease activity have been adapted for capillary blood and dried blood card samples.

Schreiber, U et al.·MethodsX·2020·Preliminary Evidencemethods paper
RPEP-05117Methods paperPreliminary Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
methods paper
Evidence
Preliminary Evidence
Sample
N=not applicable
Participants
Laboratory validation study (no patient population)

What This Study Found

Substance P and bradykinin neuropeptide reporter assays were successfully adapted from serum to capillary blood and dried blood card formats, expanding their utility for inflammation and pain research.

Key Numbers

2 neuropeptide reporters; 3 sample types (serum, capillary blood, dried blood cards)

How They Did This

Protocol development adapting existing serum-based neuropeptide protease assays (substance P and bradykinin) for use with capillary blood and dried blood card samples. Comparison with established serum protocols.

Why This Research Matters

Measuring protease activity is important for inflammation and pain research. Using finger-prick blood and dried blood cards instead of venous blood draws makes sample collection easier, especially in clinical settings or remote locations.

The Bigger Picture

Simplified sample collection methods expand access to protease activity monitoring, potentially enabling point-of-care testing and large-scale epidemiological studies in inflammation and pain research.

What This Study Doesn't Tell Us

Methods paper — demonstrates protocols without large-scale validation. Sensitivity differences between sample types need characterization. Clinical utility not yet established.

Questions This Raises

  • ?How do protease activity measurements from blood cards compare quantitatively to fresh serum?
  • ?Could this assay be used as a clinical biomarker for inflammatory conditions?
  • ?Can other neuropeptide substrates expand the protease panel measurable from dried blood?

Trust & Context

Key Stat:
Finger-prick compatible Neuropeptide protease assays adapted from venous blood to capillary blood and dried blood cards
Evidence Grade:
Preliminary — protocol development with validation data but not yet clinically validated at scale.
Study Age:
Published in 2020; dried blood card-based assays continue to expand in biomarker research.
Original Title:
Neuropeptide reporter assay for serum, capillary blood and blood cards.
Published In:
MethodsX, 7, 100985 (2020)
Database ID:
RPEP-05117

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Why use neuropeptides to measure protease activity?

Substance P and bradykinin are naturally broken down by specific proteases in blood. By adding a known amount and measuring how quickly it degrades, you can quantify protease activity — a marker that changes in inflammation and pain conditions.

What are dried blood cards and why are they useful?

Dried blood cards (like Guthrie cards used for newborn screening) collect a few drops of blood on filter paper that can be stored and shipped without refrigeration. This makes sample collection possible in any setting without special equipment.

Read More on RethinkPeptides

Cite This Study

RPEP-05117·https://rethinkpeptides.com/research/RPEP-05117

APA

Schreiber, U; Engl, C; Bayer, M; König, S. (2020). Neuropeptide reporter assay for serum, capillary blood and blood cards.. MethodsX, 7, 100985. https://doi.org/10.1016/j.mex.2020.100985

MLA

Schreiber, U, et al. "Neuropeptide reporter assay for serum, capillary blood and blood cards.." MethodsX, 2020. https://doi.org/10.1016/j.mex.2020.100985

RethinkPeptides

RethinkPeptides Research Database. "Neuropeptide reporter assay for serum, capillary blood and b..." RPEP-05117. Retrieved from https://rethinkpeptides.com/research/schreiber-2020-neuropeptide-reporter-assay-for

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.